e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood eosinophil count in the general population: typical values and potential confounders
Sylvia Hartl, Marie-Kathrin Breyer, Otto C. Burghuber, Alina Ofenheimer, Andrea Schrott, Matthias H. Urban, Alvar Agusti, Michael Studnicka, Emiel F.M. Wouters, Robab Breyer-Kohansal
Source:
Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sylvia Hartl, Marie-Kathrin Breyer, Otto C. Burghuber, Alina Ofenheimer, Andrea Schrott, Matthias H. Urban, Alvar Agusti, Michael Studnicka, Emiel F.M. Wouters, Robab Breyer-Kohansal. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Budesoinde/formoterol: does eosinophil count cause different outcomes?
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
The search for the “healthy” blood eosinophil count
Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020
Year: 2020
LATE-BREAKING ABSTRACT: Additive role of exhaled NO and blood eosinophil count to predict wheezing in a random population sample
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis
Source: Eur Respir J, 59 (1) 2004590; 10.1183/13993003.04590-2020
Year: 2022
Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Determinants of blood eosinophil count in adults from a large population-based study
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease
Source: Eur Respir J 2016; 47:1299-1303
Year: 2016
Blood eosinophil counts and degree of allergen sensitization as age dependent correlations in children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 452s
Year: 2001
Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up.
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet
Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017
Year: 2017
The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018
Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020
Lack of seasonal variability of blood eosinophil counts in COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Blood eosinophil counts in COPD patients compared to controls
Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept